Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd. scores highest on Nitro (85) and lowest on Price (8). Its PosiPenta is 49.85 out of 100, around the middle of similar companies.
On the Penta Grid this week, Kobayashi Pharmaceutical Co., Ltd. is Grid #82 of 146 in the Consumer Defensive sector in Japan, and Grid #1,043 of 2,058 in Japan.
Compared with similar companies in the Consumer Defensive sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Kobayashi Pharmaceutical Co., Ltd. | 49.85 | 8 | 57 | 85 | 50 | 50 |
| Takara Holdings Inc. | 37.42 | 15 | 49 | 63 | 25 | 34 |
| Nichirei Corporation | 48.66 | 37 | 65 | 57 | 45 | 39 |
| NH Foods Ltd. | 51.55 | 62 | 69 | 29 | 33 | 64 |
| Nisshin Seifun Group Inc. | 51.55 | 53 | 49 | 65 | 48 | 43 |
| TRIAL Holdings, Inc. | 32.69 | 5 | 56 | 45 | 10 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 322.34 |
| P/B ratio | 2.46 |
EEarnings
| Trailing EPS | ₹12.95 |
| Forward EPS | ₹142.33 |
NNitro
| Price | 4175.62 |
| 52-week high | 4453.52 |
| 52-week low | 3032.10 |
| Fall from 52-week high | 6.2% |
TTorque
| Return on equity (ROE) | 0.78% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.20 |
| Market cap | ₹31,041 Cr |
| Insider holding | 30.80% |
| Dividend yield | 1.48% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Kobayashi Pharmaceutical Co., Ltd.'s PosiPenta score?
Kobayashi Pharmaceutical Co., Ltd.'s PosiPenta is 49.85 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Kobayashi Pharmaceutical Co., Ltd. stand on the Penta Grid?
On the Penta Grid this week, Kobayashi Pharmaceutical Co., Ltd. is Grid #82 of 146 in the Consumer Defensive sector in Japan, and Grid #1,043 of 2,058 in Japan.
Which PosiPenta pillar is strongest for Kobayashi Pharmaceutical Co., Ltd.?
Nitro (momentum), with a score of 85 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Kobayashi Pharmaceutical Co., Ltd.?
Price (valuation), with a score of 8 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.